Synergistic interactions between anticancer chemotherapeutics and phenolic compounds and anticancer synergy between
Urszula Lewandowska1, Sylwia Gorlach2, Katarzyna Owczarek1
1Department of Biochemistry, Medical University of Lodz, Lodz, Poland.
Abstract:
Chemoprevention has recently gained a new dimension due to the possibility of studying the mechanisms of action of chemopreventive agents at the molecular level. Many compounds have been proved to inhibit early stages of carcinogenesis in experimental models. These compounds include both recognized drugs (such as tamoxifen and nonsteroidal anti-inflammatory drugs) and natural constituents of edible and therapeutic plants, particularly polyphenols. Phenolics are characterized by high structural diversity and, consequently, a very broad spectrum of biological activities. They are increasingly looked upon as a valuable alternative or a support for synthetic drugs, as evidenced by a growing number of clinical trials regarding the use of phenolic compounds and polyphenol-rich extracts in chemoprevention and therapy. In the present work, we discuss the effectiveness of natural polyphenols as cancer preventive and therapeutic agents resulting from their synergy with synthetic or semisynthetic anticancer drugs as well as with other phenolic compounds of plant origin.
Insights
Natural polyphenols show promise in cancer prevention and therapy. These plant-derived compounds can work synergistically with synthetic drugs and other phenolics, offering a valuable approach to chemoprevention.
Area of Science:
- Oncology
- Molecular Biology
- Pharmacology
Background:
- Chemoprevention research is advancing through molecular-level studies of agent mechanisms.
- Carcinogenesis inhibition has been demonstrated in experimental models by various compounds.
- Polyphenols from plants are recognized for their diverse biological activities and potential in cancer treatment.
Purpose of the Study:
- To discuss the efficacy of natural polyphenols in cancer prevention and therapy.
- To explore the synergistic effects of polyphenols with synthetic anticancer drugs.
- To evaluate the combined use of different plant-derived phenolic compounds.
Main Methods:
- Review of existing literature on chemopreventive agents and their mechanisms.
- Analysis of experimental models demonstrating inhibition of carcinogenesis.
- Examination of clinical trial data for phenolic compounds and polyphenol-rich extracts.
Main Results:
- Natural polyphenols exhibit significant potential as chemopreventive agents.
- Synergy observed between natural polyphenols and synthetic/semisynthetic anticancer drugs.
- Plant-derived phenolics demonstrate broad-spectrum biological activities relevant to cancer therapy.
Conclusions:
- Natural polyphenols are effective cancer preventive and therapeutic agents.
- The synergistic action of polyphenols enhances their anticancer efficacy.
- Polyphenols represent a valuable alternative or adjunct to conventional cancer treatments.
More Related Videos
07:40A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
Published on: May 27, 2021
12:00Extraction and Purification of Polyphenols from Freeze-dried Berry Powder for the Treatment of Vascular Smooth Muscle Cells In Vitro
Published on: July 5, 2017
Related Concept Videos
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Combined Effects of Drugs: Antagonism
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
Pharmacokinetics: Drug–Drug Interactions
